tradingkey.logo

Bausch + Lomb Corp

BLCO

15.190USD

-0.190-1.24%
終値 09/19, 16:00ET15分遅れの株価
5.37B時価総額
損失額直近12ヶ月PER

Bausch + Lomb Corp

15.190

-0.190-1.24%
詳細情報 Bausch + Lomb Corp 企業名
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
企業情報
企業コードBLCO
会社名Bausch + Lomb Corp
上場日May 06, 2022
最高経営責任者「CEO」Mr. Brenton L. (Brent) Saunders, J.D.
従業員数13500
証券種類Ordinary Share
決算期末May 06
本社所在地520 Applewood Crescent
都市VAUGHAN
証券取引所NYSE Consolidated
Canada
郵便番号L4K 4B4
電話番号19082552864
ウェブサイトhttps://ir.bausch.com/
企業コードBLCO
上場日May 06, 2022
最高経営責任者「CEO」Mr. Brenton L. (Brent) Saunders, J.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Brenton L. (Brent) Saunders, J.D.
Mr. Brenton L. (Brent) Saunders, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
352.13K
+162.32%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+8.63%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+35.10%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
64.91K
+53.22%
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
62.09K
+55.01%
Mr. A. Robert D. Bailey, J.D.
Mr. A. Robert D. Bailey, J.D.
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Mr. Andrew J. Stewart
Mr. Andrew J. Stewart
President - Global Pharmaceuticals and International Consumer
President - Global Pharmaceuticals and International Consumer
--
--
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Brenton L. (Brent) Saunders, J.D.
Mr. Brenton L. (Brent) Saunders, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
352.13K
+162.32%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
77.36K
+8.63%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
68.18K
+35.10%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
64.91K
+53.22%
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
62.09K
+55.01%
Mr. A. Robert D. Bailey, J.D.
Mr. A. Robert D. Bailey, J.D.
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Devices
448.00M
39.40%
OTC
409.00M
35.97%
Pharmaceuticals
222.00M
19.53%
Branded and other Generics
54.00M
4.75%
Other revenues
4.00M
0.35%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Devices
448.00M
39.40%
OTC
409.00M
35.97%
Pharmaceuticals
222.00M
19.53%
Branded and other Generics
54.00M
4.75%
Other revenues
4.00M
0.35%
株主
更新時刻: Mon, Aug 18
更新時刻: Mon, Aug 18
株主統計
種類
株主統計
株主統計
比率
Bausch Health Companies Inc
87.69%
Icahn Associates Corporation
0.99%
Deutsche Bank Securities Inc.
0.96%
Alberta Investment Management Corporation
0.92%
D. E. Shaw & Co., L.P.
0.74%
他の
8.70%
株主統計
株主統計
比率
Bausch Health Companies Inc
87.69%
Icahn Associates Corporation
0.99%
Deutsche Bank Securities Inc.
0.96%
Alberta Investment Management Corporation
0.92%
D. E. Shaw & Co., L.P.
0.74%
他の
8.70%
種類
株主統計
比率
Corporation
87.70%
Hedge Fund
3.49%
Investment Advisor/Hedge Fund
3.32%
Research Firm
1.54%
Investment Advisor
1.53%
Sovereign Wealth Fund
0.92%
Individual Investor
0.48%
Pension Fund
0.25%
Family Office
0.24%
他の
0.54%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
263
350.71M
99.08%
-19.09M
2025Q1
273
350.60M
99.12%
-19.40M
2024Q4
262
347.48M
98.58%
-23.77M
2024Q3
257
349.38M
99.14%
-19.72M
2024Q2
260
352.10M
99.92%
-21.43M
2024Q1
247
349.79M
99.91%
-25.18M
2023Q4
237
351.31M
100.35%
-21.66M
2023Q3
219
355.43M
101.52%
-16.80M
2023Q2
207
357.28M
102.06%
-12.23M
2023Q1
194
356.91M
101.97%
-11.11M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Bausch Health Companies Inc
310.45M
87.77%
--
--
Mar 24, 2025
Icahn Associates Corporation
3.50M
0.99%
--
--
Mar 31, 2025
Deutsche Bank Securities Inc.
3.50M
0.99%
+3.50M
--
Mar 31, 2025
Alberta Investment Management Corporation
3.27M
0.92%
+258.00K
+8.58%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.88M
0.53%
-6.18K
-0.33%
Mar 31, 2025
GoldenTree Asset Management, LP
2.25M
0.64%
+516.07K
+29.79%
Mar 31, 2025
Whitebox Advisors, L.L.C.
1.62M
0.46%
+179.78K
+12.46%
Mar 31, 2025
Nomura Securities Co., Ltd.
1.26M
0.36%
--
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
銘柄名
比率
Invesco RAFI Developed Mkts ex-US SM ETF
0%
Schwab Fundamental International Small Equity ETF
0%
BNY Mellon US Small Cap Core Equity ETF
0%
Goldman Sachs MarketBeta US 1000 Equity ETF
0%
Invesco Zacks Mid-Cap ETF
0%
First Trust US Equity Opportunities ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Ballast Small/Mid Cap ETF
0%
Renaissance IPO ETF
0%
Invesco RAFI Developed Mkts ex-US SM ETF
比率0%
Schwab Fundamental International Small Equity ETF
比率0%
BNY Mellon US Small Cap Core Equity ETF
比率0%
Goldman Sachs MarketBeta US 1000 Equity ETF
比率0%
Invesco Zacks Mid-Cap ETF
比率0%
First Trust US Equity Opportunities ETF
比率0%
DFA Dimensional International Core Equity 2 ETF
比率0%
Ballast Small/Mid Cap ETF
比率0%
Renaissance IPO ETF
比率0%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI